|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi J, Hua X, Zhu B, Ravichandran S, Wang
M, Nguyen C, Brodie SA, Palleschi A, Alloisio M, Pariscenti G, et
al: Somatic genomics and clinical features of lung adenocarcinoma:
A retrospective study. PLoS Med. 13:e10021622016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shah DR and Masters GA: Precision medicine
in lung cancer treatment. Surg Oncol Clin N Am. 29:15–21. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ungureanu A, Zlatian O, Mitroi G, Drocaş
A, Ţîrcă T, Călina D, Dehelean C, Docea AO, Izotov BN, Rakitskii
VN, et al: Staphylococcus aureus colonisation in patients
from a primary regional hospital. Mol Med Rep. 16:8771–8780. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zlatian O, Balasoiu AT, Balasoiu M,
Cristea O, Docea AO, Mitrut R, Spandidos DA, Tsatsakis AM, Bancescu
G and Calina D: Antimicrobial resistance in bacterial pathogens
among hospitalised patients with severe invasive infections. Exp
Ther Med. 16:4499–4510. 2018.PubMed/NCBI
|
|
7
|
Tanase A, Colita A, Ianosi G, Neagoe D,
Branisteanu DE, Calina D, Docea AO, Tsatsakis A and Ianosi SL: Rare
case of disseminated fusariosis in a young patient with graft vs.
host disease following an allogeneic transplant. Exp Ther Med.
12:2078–2082. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Foltz DR, Jansen LE, Bailey AO, Yates JR
3rd, Bassett EA, Wood S, Black BE and Cleveland DW:
Centromere-specific assembly of CENP-a nucleosomes is mediated by
HJURP. Cell. 137:472–484. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dunleavy EM, Roche D, Tagami H, Lacoste N,
Ray-Gallet D, Nakamura Y, Daigo Y, Nakatani Y and
Almouzni-Pettinotti G: HJURP is a cell-cycle-dependent maintenance
and deposition factor of CENP-A at centromeres. Cell. 137:485–497.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barnhart MC, Kuich PH, Stellfox ME, Ward
JA, Bassett EA, Black BE and Foltz DR: HJURP is a CENP-A chromatin
assembly factor sufficient to form a functional de novo
kinetochore. J Cell Biol. 194:229–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kato T, Sato N, Hayama S, Yamabuki T, Ito
T, Miyamoto M, Kondo S, Nakamura Y and Daigo Y: Activation of
Holliday junction recognizing protein involved in the chromosomal
stability and immortality of cancer cells. Cancer Res.
67:8544–8553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mishra PK, Au WC, Choy JS, Kuich PH, Baker
RE, Foltz DR and Basrai MA: Misregulation of Scm3p/HJURP causes
chromosome instability in Saccharomyces cerevisiae and human cells.
PLoS Genet. 7:e10023032011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shuaib M, Ouararhni K, Dimitrov S and
Hamiche A: HJURP binds CENP-A via a highly conserved N-terminal
domain and mediates its deposition at centromeres. Proc Natl Acad
Sci U S A. 107:1349–1354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu B, Wang Q, Wang Y, Chen J, Li P and Han
M: Holliday junction-recognizing protein promotes cell
proliferation and correlates with unfavorable clinical outcome of
hepatocellular carcinoma. Onco Targets Ther. 10:2601–2607. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valente V, Serafim RB, de Oliveira LC,
Adorni FS, Torrieri R, Tirapelli DP, Espreafico EM, Oba-Shinjo SM,
Marie SK, Paçó-Larson ML and Carlotti CG Jr: Modulation of HJURP
(Holliday junction-recognizing protein) levels is correlated with
glioblastoma cells survival. PLoS One. 8:e622002013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Montes de Oca R, Gurard-Levin ZA, Berger
F, Rehman H, Martel E, Corpet A, de Koning L, Vassias I, Wilson LO,
Meseure D, et al: The histone chaperone HJURP is a new independent
prognostic marker for luminal A breast carcinoma. Mol Oncol.
9:657–674. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li L, Li X, Meng Q, Khan AQ and Chen X:
Increased expression of Holliday junction-recognizing protein
(HJURP) as an independent prognostic biomarker in advanced-stage
serous ovarian carcinoma. Med Sci Monit. 24:3050–3055. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Askar N, Cirpan T, Toprak E, Karabulut B,
Selvi N, Terek MC, Uslu R, Sanli UA and Goker E: Arsenic trioxide
exposure to ovarian carcinoma cells leads to decreased level of
topoisomerase II and cytotoxicity. Int J Gynecol Cancer.
16:1552–1556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeng C, Shao Z, Wei Z, Yao J, Wang W, Yin
L, YangOu H and Xiong D: The NOTCH-HES-1 axis is involved in
promoting Th22 cell differentiation. Cell Mol Biol Lett. 26:72021.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moreno Leon L, Gautier M, Allan R, Ilié M,
Nottet N, Pons N, Paquet A, Lebrigand K, Truchi M, Fassy J, et al:
The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA
contributes to an aggressive phenotype in lung adenocarcinoma
through regulation of oxidative stress. Oncogene. 38:7146–7165.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ramos M, Franch P, Zaforteza M, Artero J
and Durán M: Completeness of T, N, M and stage grouping for all
cancers in the mallorca cancer registry. BMC Cancer. 15:8472015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES, et al: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci U S A. 102:15545–15550. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ru B, Wong CN, Tong Y, Zhong JY, Zhong SS,
Wu WC, Chu KC, Wong CY, Lau CY, Chen I, et al: TISIDB: An
integrated repository portal for tumor-immune system interactions.
Bioinformatics. 35:4200–4202. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei Y, Ouyang GL, Yao WX, Zhu YJ, Li X,
Huang LX, Yang XW and Jiang WJ: Knockdown of HJURP inhibits
non-small cell lung cancer cell proliferation, migration, and
invasion by repressing Wnt/β-catenin signaling. Eur Rev Med
Pharmacol Sci. 23:3847–3856. 2019.PubMed/NCBI
|
|
25
|
Zhou D, Tang W, Liu X, An HX and Zhang Y:
Clinical verification of plasma messenger RNA as novel noninvasive
biomarker identified through bioinformatics analysis for lung
cancer. Oncotarget. 8:43978–43989. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dhieb D, Belguith I, Capelli L, Chiadini
E, Canale M, Bravaccini S, Yangui I, Boudawara O, Jlidi R,
Boudawara T, et al: Analysis of genetic alterations in tunisian
patients with lung adenocarcinoma. Cells. 8:5142019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng MM, Li YS, Jiang BY, Tu HY, Tang WF,
Yang JJ, Zhang XC, Ye JY, Yan HH, Su J, et al: Clinical utility of
cerebrospinal fluid cell-free DNA as liquid biopsy for
leptomeningeal metastases in ALK-rearranged NSCLC. J Thorac Oncol.
14:924–932. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Varn FS, Tafe LJ, Amos CI and Cheng C:
Computational immune profiling in lung adenocarcinoma reveals
reproducible prognostic associations with implications for
immunotherapy. Oncoimmunology. 7:e14310842018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang W, Ren S, Wang Z, Zhang C and Huang
J: Increased expression of TTC21A in lung adenocarcinoma infers
favorable prognosis and high immune infiltrating level. Int
Immunopharmacol. 78:1060772020. View Article : Google Scholar : PubMed/NCBI
|
